What is Jackson Acquisition Company II's market cap?

Jackson Acquisition Company II (JACS) has a market capitalization of $314.7M and trades on NYSE.

Who are Jackson Acquisition Company II's competitors?

Jackson Acquisition Company II's key competitors include Cantor Equity Partners II, Inc. Class A Ordinary Share, Enhanced Group Inc. Class A, Churchill Capital Corp IX Ordinary Shares, and others. These companies compete in similar markets and product categories.

Who does Jackson Acquisition Company II partner with?

Jackson Acquisition Company II's notable partners include Roth Capital Partners, Continental Stock Transfer & Trust Company, New York Stock Exchange.

Where is Jackson Acquisition Company II headquartered?

Jackson Acquisition Company II is headquartered in United States of America. It has been publicly traded since 2025.

JAC

Jackson Acquisition Company II

JACS

Market cap

$314.69M+3.1%

Net income$8.9M—

Trailing twelve months · change vs. prior year

Table of contents

Financials

Income statement

See full

Operating income-$168.3K+18.4%

Net income$2.0M-11.6%

EPS (diluted)$0.07-12.5%

Balance sheet

See full

Cash & equivalents$393.5K-48.0%

Total equity$52.5K-91.0%

Total assets$245.2M+3.8%

Cash flow

See full

Operating cash flow-$128.3K+33.7%

Valuation & ratios

Valuation

See full

Market cap$314.69M+3.1%

P/E35.5×—

Returns & leverage

See full

Return on equity2,785.2%—

Current ratio1.1×-1.2×

Competitors

By market cap

CEP

Cantor Equity Partners IV, Inc. Class A Ordinary Shares$592.6M

CCI

Churchill Capital Corp IX$398.9M

ENH

Enhanced Group Inc. Class A$389.0M

BDC

BTC Development Corp. $349.6M

ATI

Archimedes Tech SPAC Partners II Co. Ordinary Shares$321.1M

ALD

Aldel Financial II Inc.$318.4M

JAC

Jackson Acquisition Company II$314.7M

CEP

Cantor Equity Partners II, Inc. Class A Ordinary Share$310.4M

Profile

Jackson Acquisition Company II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, or similar business combination with one or more operating businesses. The company primarily focuses on identifying high-quality targets within the healthcare services and healthcare technology sectors, leveraging its management's expertise in multi-site healthcare operations and integration.

Competitive position

A newly formed blank check company competing with other SPACs and private equity firms for healthcare-related acquisition targets.

GeographiesGlobal, United States

Customer segmentsPublic Market Investors

Business modelSPAC

SuppliersCapital from IPO proceeds, Sponsor funding, Investment banking services, Legal and accounting advisory

CustomersTarget healthcare businesses, Public equity markets

CountryUnited States of America

Listed2025

CEORichard L. Jackson

SectorBLANK CHECKS

IndustryBLANK CHECKS

FilingsSEC EDGAR

Questions, answered.

What is Jackson Acquisition Company II's market cap?: Jackson Acquisition Company II (JACS) has a market capitalization of $314.7M and trades on NYSE.
Who are Jackson Acquisition Company II's competitors?: Jackson Acquisition Company II's key competitors include Cantor Equity Partners II, Inc. Class A Ordinary Share, Enhanced Group Inc. Class A, Churchill Capital Corp IX Ordinary Shares, and others. These companies compete in similar markets and product categories.
Who does Jackson Acquisition Company II partner with?: Jackson Acquisition Company II's notable partners include Roth Capital Partners, Continental Stock Transfer & Trust Company, New York Stock Exchange.
Where is Jackson Acquisition Company II headquartered?: Jackson Acquisition Company II is headquartered in United States of America. It has been publicly traded since 2025.